Get the Stockscreener App
25.39
0.12%
0.03
After Hours:
25.39
Xoma Corporation stock is traded at $25.39, with a volume of 1,840.
It is up +0.12% in the last 24 hours and down -0.66% over the past month.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
See More
Previous Close:
$25.36
Open:
$25.38
24h Volume:
1,840
Relative Volume:
0.36
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.55%
1M Performance:
-0.66%
6M Performance:
+0.77%
1Y Performance:
+11.36%
1-Day Range:
$25.28
$25.39
1-Week Range:
$25.25
$25.39
52-Week Range:
$22.06
$25.87
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Compare XOMAO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMAO
Xoma Corporation
|
25.39 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.13 | 120.56B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
750.22 | 82.44B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
616.55 | 36.87B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.07 | 32.64B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.39 | 28.38B | 3.30B | -501.07M | 1.03B | -2.1146 |
Xoma Corporation Stock (XOMAO) Latest News
XOMA Co. (NASDAQ:XOMAO) Short Interest Down 96.0% in November - Defense World
How the (XOMAP) price action is used to our Advantage - Stock Traders Daily
(XOMA) Investment Report - Stock Traders Daily
XOMA Stock Soars to 52-Week High, Reaching $34 Amidst Strong Growth - Investing.com India
XOMA (NASDAQ:XOMAO) Stock Price Down 0.3% – Should You Sell? - Defense World
(XOMAP) Technical Data - Stock Traders Daily
Short Interest in XOMA Co. (NASDAQ:XOMA) Drops By 23.5% - Defense World
How To Trade (XOMAO) - Stock Traders Daily
(XOMA) Technical Data - Stock Traders Daily
XOMA Co. (NASDAQ:XOMA) Sees Large Decrease in Short Interest - MarketBeat
Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 - Investing.com India
Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 By Investing.com - Investing.com Australia
Xoma CEO Owen Hughes sells $655,335 in stock By Investing.com - Investing.com Australia
Xoma CEO Owen Hughes sells $655,335 in stock - Investing.com India
What Makes XOMA Royalty (XOMA) a New Buy Stock - Yahoo Finance
XOMA Royalty Reports Third Quarter 2024 Financial Results and Recent Activities - Defense World
What is HC Wainwright's Forecast for XOMA FY2025 Earnings? - MarketBeat
XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance
XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
XOMA Royalty’s Third Quarter 2024 Financial Insights - TipRanks
XOMA Royalty: Q3 Earnings Snapshot - CT Insider
XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - ForexTV.com
Xoma reports Q3 EPS ($1.59), consensus (44c) - TipRanks
XOMA Royalty Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News - StockTitan
XOMA stock soars to 52-week high, reaching $32 By Investing.com - Investing.com UK
XOMA stock soars to 52-week high, reaching $32 - Investing.com
When (XOMAO) Moves Investors should Listen - Stock Traders Daily
How the (XOMA) price action is used to our Advantage - Stock Traders Daily
XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World
XOMA Royalty Corporation's (NASDAQ:XOMA) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Simply Wall St
XOMA stock soars to 52-week high, reaching $30.7 By Investing.com - Investing.com South Africa
XOMA stock soars to 52-week high, reaching $30.7 - Investing.com India
XOMA’s (XOMA) Buy Rating Reaffirmed at HC Wainwright - Defense World
XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October - Defense World
(XOMA) On The My Stocks Page - Stock Traders Daily
Twist Bioscience enters into purchase agreement with XOMA Royalty - MSN
XOMA (NASDAQ:XOMA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
XOMA Royalty Corporation Acquires 50% of Twist's Existing Royalty and Milestone Economics for $15 Million - Marketscreener.com
XOMA Royalty Significantly Expands its Royalty and - GlobeNewswire
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - The Bakersfield Californian
XOMA stock hits 52-week high at $26.48 amid market optimism - Investing.com Australia
Twist Bioscience secures $15 million capital boost By Investing.com - Investing.com UK
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.61%
1.14%
Cap:
|
Volume (24h):